cranial nerve malignant neoplasm: Benign and malignant neoplasms that arise from one or more of the twelve cranial nerves.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1011 |
4. Check minimum number of eventsNone |
1011 |
5. Include endpointsNone |
1011 |
6. Filter based on genotype QC (FinnGen only) |
1011 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D33
- Name in latin
- Neoplasma benignum nervi cranialis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Cranial nerves
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Cranial nerves
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 6100 | 3369 | 2687 |
| Only index persons | 5447 | 3043 | 2404 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.09 | 0.10 | 0.08 |
| Only index persons | 0.10 | 0.11 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 56.38 | 56.92 | 55.69 |
| Only index persons | 55.98 | 56.46 | 55.36 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1011 | 570 | 441 |
| Unadjusted period prevalence (%) | 0.19 | 0.19 | 0.19 |
| Median age at first event (years) | 56.65 | 55.49 | 58.16 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 896
- Matched controls
- 8959
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D33.30
ICD-10 Finland
Acoustic neuroma
4503599627370496.0
323.0
744
*
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
99.1
251.8
271
39
9560/0-C72.4
ICD-O-3
Schwannoma, NOS, of acoustic nerve
+∞
236.2
216
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
63.2
164.2
190
38
DFF00
NOMESCO Finland
Pure tone audiometry
10.2
135.0
298
418
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
16.7
131.2
220
171
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
9.6
111.1
249
345
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
47.2
100.8
123
30
D33.3
ICD-10 Finland
Benign neoplasm: Cranial nerves
+∞
85.8
81
*
D33.39
ICD-10 Finland
Benign tumor of the cranial nerves UNS
+∞
84.7
80
*
D33.37
ICD-10 Finland
Another benign tumor of the cranial nerves
+∞
82.6
78
*
2251A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cranial nerves
+∞
82.6
78
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
5.2
77.7
284
733
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
4.6
73.6
308
909
DFF15
NOMESCO Finland
Speech audiometry
9.5
67.5
146
179
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
36.4
66.9
86
26
DFF59
NOMESCO Finland
Other assessment of balance
26.6
56.1
78
32
G51.0
ICD-10 Finland
Bell palsy
11.0
49.8
98
99
22510
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Cranial nerves (including optic)
+∞
49.4
47
*
AAE32
NOMESCO Finland
Translabyrinthine excision acoustic neurinome
+∞
47.3
45
*
CBK11
NOMESCO Finland
Operation for lagophtalmus with implant
96.9
42.2
46
5
AAE34
NOMESCO Finland
Other operations on acoustical nerv
+∞
38.8
37
*
H02.2
ICD-10 Finland
Lagophthalmos
51.3
36.9
44
9
N07CA01
ATC
betahistine; oral
4.3
36.2
148
397
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
8.8
34.6
76
93
9560/0-C72.5
ICD-O-3
Schwannoma, NOS, of cranial nerve, NOS
+∞
34.6
33
*
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
96.4
34.0
37
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
9.1
33.0
71
84
Z3229
NOMESCO Finland
Other healthcare associate professional
3.8
31.0
142
420
UDC00
NOMESCO Finland
Ear microscopy
4.1
27.8
114
304
H93.1
ICD-10 Finland
Tinnitus
4.1
27.5
113
302
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
11.7
26.9
50
45
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
139.0
25.7
27
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.7
25.4
120
361
2152
FHL
Extraction, big brain
40.1
25.0
31
8
DE2CM
NOMESCO Finland
Acoustic channel extensive MRI examination with 3 Tesla magnet
57.7
24.1
28
5
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
21.8
193
878
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
15.3
20.8
34
23
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
3.6
20.8
99
299
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
214.7
20.7
21
*
WF099
NOMESCO Finland
Other radiotherapy
16.5
20.2
32
20
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
6.2
19.8
54
92
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
25.2
19.6
27
11
D32.06
ICD-10 Finland
Benign tumor of the meninges os petrosum or clivus area
71.4
18.8
21
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.9
18.8
406
2706
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
12.6
18.7
33
27
R5120
NOMESCO Finland
Preparation of an aid
5.6
18.3
54
102
AA1AD
NOMESCO Finland
CT of head and brain
2.1
18.0
257
1452
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
7.3
18.0
43
61
R42
ICD-10 Finland
Dizziness and giddiness
2.1
17.3
237
1312
ZZC00
NOMESCO Finland
Graft of fascia
64.6
16.8
19
*
9560/0-C72.9
ICD-O-3
Schwannoma, NOS, of nervous system, NOS
+∞
16.7
16
*
ZXC40
NOMESCO Finland
Use of ultrasound
11.9
16.6
30
26
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.5
15.3
74
227
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
8.9
14.8
31
36
ZX050
NOMESCO Finland
Stereotactic radiotherapy
13.5
14.8
25
19
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
36.7
14.5
18
5
ZXE20
NOMESCO Finland
More than three and less than five hours
2.2
14.4
156
772
8000/0-C72.4
ICD-O-3
Neoplasm, benign of acoustic nerve
+∞
13.6
13
*
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
3.4
13.5
65
199
CBH30
NOMESCO Finland
Tarsorraphy
142.0
13.5
14
*
DE2DG
NOMESCO Finland
Acoustic channel very extensive MRI examination with high intensity magnet
142.0
13.5
14
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
12.9
362
2528
H91.9
ICD-10 Finland
Hearing loss, unspecified
3.5
12.9
60
179
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
14.3
12.8
21
15
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
12.8
267
1698
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
4.5
12.7
45
105
DAX08
NOMESCO Finland
Fitting of hearing aid
3.5
12.6
60
182
G91.1
ICD-10 Finland
Obstructive hydrocephalus
18.3
12.1
18
10
3252
FHL
Repair with foreign material (spring, magnet)
+∞
11.5
11
*
D33.03
ICD-10 Finland
Pilosytic lateral astrocytoma of the strobe brain
+∞
11.5
11
*
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
35.5
11.3
14
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.2
11.2
122
603
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
6.5
11.1
28
44
H02
ICPC
Hearing complaint
2.2
11.0
123
616
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
43.9
10.9
13
*
DE2BM
NOMESCO Finland
Acoustic channel MRI examination with 3 Tesla magnet
43.9
10.9
13
*
CBH25
NOMESCO Finland
Tarsorrhaphy
28.4
10.7
14
5
AAH50
NOMESCO Finland
Cranial nerve anastomosis
111.2
10.4
11
*
Q85.1
ICD-10 Finland
Tuberous sclerosis
111.2
10.4
11
*
H47.1
ICD-10 Finland
Papilloedema, unspecified
19.0
10.3
15
8
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
11.5
10.1
18
16
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
40.5
10.0
12
*
Z97.4
ICD-10 Finland
Presence of external hearing-aid
3.0
9.8
56
194
QAJ10
NOMESCO Finland
Browlift
10.8
9.8
18
17
G50.0
ICD-10 Finland
Trigeminal neuralgia
5.6
9.7
27
49
XX3DW
NOMESCO Finland
Time consuming IT work
2.1
9.7
109
546
WF002
NOMESCO Finland
Radical radiotherapy
2.8
9.6
61
228
CBW99
NOMESCO Finland
Other operation on eyelid
101.0
9.4
10
*
CBK99
NOMESCO Finland
Other operation for retraction of eyelid
+∞
9.4
9
*
R5140
NOMESCO Finland
Monitoring the use of the aid
2.1
9.4
103
512
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
13.8
9.2
15
11
R4110
NOMESCO Finland
Physiotherapy
1.7
9.1
246
1667
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
10.2
9.0
17
17
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
8.8
211
1379
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
50.5
8.7
10
*
WX110
NOMESCO Finland
Local anesthesy
1.5
8.6
573
4801
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
11.7
8.6
15
13
N03AF01
ATC
carbamazepine; oral, rectal
2.7
8.5
58
227
D32.05
ICD-10 Finland
Cerebral meninges
27.8
8.5
11
*
ZZK00
NOMESCO Finland
Graft of nerve
90.9
8.4
9
*
H81.3
ICD-10 Finland
Other peripheral vertigo
3.5
8.2
36
105
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
3.6
8.0
34
96
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
22.2
8.0
11
5
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
10.9
7.8
14
13
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
45.4
7.7
9
*
H02.1
ICD-10 Finland
Ectropion of eyelid
6.8
7.6
18
27
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
18.5
7.6
11
6
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
5.2
7.6
22
43
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
25.2
7.6
10
*
H81.0
ICD-10 Finland
Ménière disease
3.6
7.4
32
92
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
5.3
7.4
21
40
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.7
7.4
30
82
DC1AD
NOMESCO Finland
Temporalbone CT
6.0
7.4
19
32
N03AF02
ATC
oxcarbazepine; oral
3.2
7.4
36
114
2159
FHL
Other measure in this category
+∞
7.3
7
*
3259
FHL
Other measure in this category
+∞
7.3
7
*
TAB00
NOMESCO Finland
Lumbar puncture
2.8
7.3
46
171
H90.5
ICD-10 Finland
Sensorineural hearing loss, unspecified
5.9
7.2
19
33
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
7.2
313
2355
SPAT1043
SPAT
Audiometry
1.9
7.1
102
564
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
10.1
7.0
13
13
R51.80
ICD-10 Finland
Headache
1.8
7.0
119
697
Z31.5
ICD-10 Finland
Genetic counselling
2.6
6.9
48
189
D36.1
ICD-10 Finland
Benign neoplasm: Peripheral nerves and autonomic nervous system
13.9
6.9
11
8
Z3226
NOMESCO Finland
Physiotherapist
1.7
6.8
168
1098
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.3
6.8
32
99
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.7
6.8
28
78
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
11.0
6.8
12
11
CBK10
NOMESCO Finland
Operation for lagophtalmus
40.4
6.8
8
*
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
40.4
6.8
8
*
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
40.4
6.8
8
*
R4135
NOMESCO Finland
Rehabilitation for hearing problems
4.3
6.6
23
55
WX402
NOMESCO Finland
General anaesthesia
1.7
6.6
139
871
ZXA05
NOMESCO Finland
Left side
1.5
6.5
230
1646
XCK00
NOMESCO Finland
Perimetry
2.1
6.4
67
326
TQA05
NOMESCO Finland
Puncture of skin of head or neck
70.3
6.4
7
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.5
6.4
49
206
D33.45
ICD-10 Finland
Benign Schwannom in the nerve root of the spinal cord
14.4
6.4
10
7
QAJ30
NOMESCO Finland
Other facelift
14.4
6.4
10
7
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
6.3
176
1190
RK520
NOMESCO Finland
NA
9.3
6.3
12
13
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
6.3
136
859
D33
ICD-10 Finland
Benign neoplasm of brain and other parts of central nervous system
+∞
6.3
6
*
9560/0-C71.9
ICD-O-3
Schwannoma, NOS, of brain, NOS
+∞
6.3
6
*
D43.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Cranial nerves
+∞
6.3
6
*
3253
FHL
Tarsoraphy
+∞
6.3
6
*
N76
ICPC
Neoplasm nervous system unspecified
26.9
6.2
8
*
CBJ50
NOMESCO Finland
Operation for ptosis of eyebrow
7.7
6.1
13
17
ZZF00
NOMESCO Finland
Graft of adipose tissue
6.8
6.0
14
21
G50.1
ICD-10 Finland
Atypical facial pain
3.8
6.0
23
61
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
58
50
12.25
57.16
1.8
1.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
397
2718
1.76
16.07
2.0
2.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
528
3984
1.68
14.49
6.3
5.9
mmol/l
1.2
1.2
0.37
488
3598
(3033658) Prothrombin time (PT) actual/Normal
326
2164
1.75
14.36
3.7
3.9
%
93.0
90.0
1.41
321
2106
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
553
4342
1.60
12.04
7.0
6.7
mmol/l
1.2
1.2
0.56
485
3669
(3013826) Glucose [Moles/volume] in Serum or Plasma
618
5062
1.57
10.60
5.1
4.8
mmol/l
6.6
6.7
1.37
596
4752
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
300
2084
1.62
10.54
1.9
2.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
167
1002
1.80
10.03
7.2
7.5
mmol/l
0.8
1.2
0.51
120
790
(3027801) Oxygen [Partial pressure] in Arterial blood
166
1005
1.78
9.65
7.2
7.5
kpa
15.9
12.1
10.31
156
968
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
166
1005
1.78
9.65
7.2
7.5
kpa
5.1
5.1
0.02
157
968
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
110
584
1.99
9.61
2.4
2.5
au/ml
28.4
18.1
—
8
24
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
101
529
2.01
9.16
1.3
1.3
au/ml
19.0
53.7
—
5
27
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
50
198
2.60
8.76
1.7
1.2
e6/l
83.2
30.4
0.35
39
152
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
50
198
2.60
8.76
1.9
1.3
e6/l
2161.9
695.5
0.34
42
158
(3044290) Cell count panel - Cerebral spinal fluid
45
173
2.68
8.37
1.7
1.2
—
—
—
0
0
(4035726)
132
778
1.80
8.36
1.2
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
432
3414
1.46
7.86
2.2
2.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
936
8728
1.98
7.59
18.3
17.2
mmol/l
139.9
139.7
1.62
920
8504
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
494
4027
1.44
7.52
3.6
4.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
27
85
3.24
7.15
2.2
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
904
8366
1.76
7.13
15.1
14.8
mg/l
24.9
24.3
0.16
735
6687
(3023103) Potassium [Moles/volume] in Serum or Plasma
935
8751
1.91
6.96
18.5
17.4
mmol/l
3.9
4.0
2.51
918
8519
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
17
42
4.10
6.37
2.2
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
25
86
2.96
5.76
2.0
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
859
7979
1.51
5.16
15.0
13.8
ml/min/173m2
79.7
79.1
0.41
727
6576
(3037467) Urinalysis macro (dipstick) panel - Urine
654
5799
1.36
5.10
4.4
4.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
422
3512
1.35
4.98
2.4
2.2
nmol/l
78.9
77.7
0.45
373
3121
(3023410) Appearance of Cerebral spinal fluid
24
92
2.65
4.59
2.1
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
938
8954
1.66
4.24
11.1
10.8
u/l
25.8
25.9
0.04
911
8637
(42870588) Differential panel, method unspecified - Blood
349
2877
1.33
4.22
6.2
5.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
827
7704
1.40
4.16
4.9
4.7
mu/l
1.9
2.1
0.83
748
6990
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
520
4538
1.30
4.11
5.8
6.3
umol/l
12.2
11.6
0.35
499
4312
(3013707) Erythrocyte sedimentation rate by Westergren method
696
6323
1.32
4.06
4.0
4.2
mm/h
11.4
12.6
1.23
637
5820
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
725
6639
1.33
3.91
7.6
7.6
u/l
78.1
78.8
0.15
684
6213
(3032080) INR in Blood by Coagulation assay
423
3615
1.29
3.84
5.7
9.3
inr
1.1
1.2
1.79
112
1024
(3024561) Albumin [Mass/volume] in Serum or Plasma
436
3755
1.28
3.68
4.2
4.6
g/l
35.8
35.3
0.96
403
3496
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
84
550
1.58
3.63
10.1
9.2
%
0.7
0.7
0.16
84
544
(3007461) Platelets [#/volume] in Blood
961
9273
1.73
3.61
23.0
21.9
e9/l
249.6
248.6
0.16
939
9034
(3024731) MCV [Entitic volume]
961
9276
1.73
3.57
23.0
21.8
fl
90.7
91.3
3.71
952
9137
(3026361) Erythrocytes [#/volume] in Blood
961
9278
1.72
3.54
23.1
21.9
e12/l
4.5
4.5
1.31
941
9016
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
320
2661
1.30
3.52
2.3
2.1
u/l
179.2
235.0
0.89
306
2506
(3000963) Hemoglobin [Mass/volume] in Blood
961
9280
1.72
3.51
23.1
22.0
g/l
134.7
134.8
0.06
954
9136
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
84
557
1.55
3.45
10.1
9.0
%
1.1
1.3
2.13
84
551
(3014007) Fractional oxyhemoglobin in Arterial blood
83
551
1.55
3.39
10.2
9.3
%
94.8
93.9
0.41
83
545
(3013650) Neutrophils [#/volume] in Blood by Automated count
548
4886
1.27
3.38
8.5
9.2
e9/l
4.2
4.1
0.20
461
4286
(3035941) MCH [Entitic mass]
960
9277
1.69
3.36
23.0
21.8
pg
30.2
30.4
2.36
951
9136
(3010813) Leukocytes [#/volume] in Blood
960
9278
1.69
3.35
23.1
21.9
e9/l
6.7
6.7
0.24
939
9013
(3022096) Basophils/100 leukocytes in Blood
440
3834
1.26
3.26
6.2
5.9
%
0.7
0.7
0.16
403
3574
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
14
49
2.88
3.20
1.7
1.3
nmol/l
19.1
19.1
0.00
14
43
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
206
1632
1.33
3.19
3.4
3.0
ug/l
0.7
0.8
0.35
139
1079
(3018010) Neutrophils/100 leukocytes in Blood
454
3980
1.26
3.16
6.0
5.7
%
57.5
57.5
0.01
419
3721
(3002030) Lymphocytes/100 leukocytes in Blood
460
4039
1.25
3.16
6.3
6.0
%
27.8
27.4
0.26
420
3755
(40758558) Short blood count panel - Blood
259
2133
1.29
3.01
5.9
6.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
542
4866
1.25
3.00
2.7
2.7
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
448
3944
1.24
2.94
6.2
5.8
%
2.8
2.8
0.19
408
3669
(3006315) Basophils [#/volume] in Blood
474
4200
1.24
2.93
6.0
5.7
e9/l
0.0
0.0
0.08
391
3637
(3019198) Lymphocytes [#/volume] in Blood
481
4278
1.24
2.85
6.0
5.7
e9/l
1.8
1.9
0.72
404
3766
(3003458) Phosphate [Moles/volume] in Serum or Plasma
150
1155
1.35
2.81
4.6
5.4
mmol/l
1.0
1.0
0.63
140
1061
(3009214) Lutropin [Units/volume] in Serum or Plasma
32
173
1.88
2.79
1.6
1.3
u/l
13.3
10.5
0.30
20
141
(3020779) Urea [Moles/volume] in Serum or Plasma
107
780
1.42
2.79
4.4
6.9
mmol/l
9.1
9.6
0.33
101
745
(3019069) Monocytes/100 leukocytes in Blood
448
3961
1.24
2.78
6.5
6.1
%
8.8
8.7
0.10
412
3702
(3001604) Monocytes [#/volume] in Blood
470
4183
1.23
2.73
6.0
5.7
e9/l
0.6
0.6
0.08
388
3611
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
202
1634
1.30
2.67
3.0
3.0
mmol/l
2.5
2.5
0.15
171
1435
(3013115) Eosinophils [#/volume] in Blood
485
4337
1.23
2.67
6.3
6.0
e9/l
0.2
0.2
0.02
404
3822
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
410
3608
1.23
2.62
2.1
2.0
pmol/l
95.2
95.2
0.00
220
1831
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
21
100
2.12
2.60
1.4
1.4
pmol/l
249.6
321.1
0.85
16
79
(40761511) CBC panel - Blood by Automated count
908
8739
1.38
2.52
14.2
14.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
304
2600
1.24
2.52
4.4
3.9
ph
7.4
7.4
0.07
49
501
(3012095) Magnesium [Moles/volume] in Serum or Plasma
177
1427
1.29
2.40
3.2
3.3
mmol/l
0.8
0.8
1.46
166
1334
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
5
8
6.27
2.37
2.6
2.8
pmol/l
58.4
91.5
—
5
8
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
8
6.27
2.37
1.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
5
8
6.27
2.37
2.0
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
340
2970
1.22
2.27
3.4
3.4
mmol/l
2.4
2.4
0.35
280
2574
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
686
6420
1.21
2.18
4.1
3.9
pmol/l
14.9
14.9
0.03
618
5807
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
592
5466
1.20
2.16
3.2
3.2
u/l
47.4
50.4
0.38
554
5077
(3026008) Bacteria identified in Urine by Culture
305
2649
1.22
2.14
2.8
3.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
40
255
1.59
2.03
2.9
3.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
16
76
2.12
2.03
1.0
1.0
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
9
32
2.83
2.00
3.1
3.1
umol/l
27.7
33.1
—
9
24
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
319
2803
1.20
1.96
5.7
5.0
ug/l
3.4
2.8
0.28
284
2501
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
53
364
1.48
1.95
2.5
2.0
u/l
36.6
39.8
0.49
46
322
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
262
2261
1.21
1.94
4.8
4.3
%
22.6
21.4
0.62
139
1082
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
65
465
1.43
1.94
11.1
9.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
16
78
2.07
1.91
2.4
3.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
733
6939
1.20
1.90
19.5
19.3
g/l
332.2
332.2
0.07
728
6891
(3019225) pH of Specimen
113
887
1.31
1.89
4.7
4.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
93
711
1.34
1.87
9.1
8.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
53
370
1.46
1.81
1.2
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
14
67
2.10
1.76
1.1
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
307
2712
1.19
1.76
3.4
3.3
u/l
36.3
32.7
0.36
291
2583
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
17
88
1.95
1.75
1.0
1.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
599
5593
1.17
1.74
4.8
4.6
e6/l
711.2
2176.2
—
10
88
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
8
30
2.68
1.72
1.5
2.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
165
1378
1.24
1.68
2.9
3.0
e6/l
2.4
2.3
0.04
86
756
(3007853) Bacteria identified in Skin by Aerobe culture
123
993
1.27
1.68
1.7
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
860
8302
1.24
1.67
4.6
4.5
mmol/l
1.5
1.5
0.33
779
7590
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
176
1482
1.23
1.66
2.8
2.8
e6/l
1.3
1.2
0.12
94
857
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
73
549
1.36
1.66
1.5
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
865
8359
1.24
1.64
4.6
4.6
mmol/l
4.7
4.6
0.69
792
7696
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
134
0.37
1.61
1.4
1.6
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
14
3.58
1.61
2.0
5.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
293
2597
1.18
1.60
3.3
3.3
e6/l
61.0
102.3
0.64
224
2017
(3030467) Casts [#/volume] in Urine by Automated count
272
2398
1.18
1.58
3.3
3.2
e6/l
0.4
0.5
0.20
201
1827
(3024869) Neuronal Ab [Presence] in Serum
6
20
3.01
1.58
1.2
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
76
583
1.33
1.53
2.3
2.2
nmol/l
11.9
13.1
0.54
65
513
(4010399)
46
638
0.71
1.50
1.2
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
407
3723
1.16
1.47
10.2
9.6
e9/l
0.0
0.0
0.08
318
3074
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
116
948
1.25
1.45
4.3
4.0
u/l
242.0
252.2
0.25
105
894
(3022145) Colonoscopy Study observation
119
977
1.25
1.43
1.4
1.3
—
—
—
0
0
(4094501)
35
237
1.49
1.43
1.1
1.1
—
—
—
0
0
(3036489) Thrombin time
43
305
1.43
1.40
2.4
1.8
s
22.1
21.6
0.24
37
274
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
50
366
1.39
1.37
1.3
1.8
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
23
2.62
1.37
1.5
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
198
1720
1.19
1.36
2.9
2.8
mosm/kgh2o
562.8
552.3
0.22
163
1479
(36304419) Bacteria [Presence] in Urine
261
2323
1.17
1.34
3.2
3.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
36
250
1.46
1.32
1.5
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
783
7539
1.17
1.31
17.7
15.9
%
40.1
39.6
0.91
573
5207
(3002385) Erythrocyte distribution width [Ratio]
721
6900
1.16
1.31
19.2
18.1
%
13.7
13.7
0.40
711
6754
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
20
318
0.62
1.31
2.8
2.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
15
256
0.58
1.30
1.3
1.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
17
99
1.73
1.27
1.8
1.2
nmol/l
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
124
1040
1.22
1.25
1.4
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
46
339
1.37
1.24
1.3
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
876
8528
1.20
1.22
5.2
5.1
mmol/l
2.8
2.7
0.88
796
7801
(3021960) Folate [Moles/volume] in Serum or Plasma
239
2128
1.16
1.22
1.5
1.5
nmol/l
21.4
20.9
0.20
190
1783
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
16
93
1.73
1.21
1.0
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
332
3028
1.14
1.21
3.8
3.8
e6/l
140.3
120.6
0.07
242
2177
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
827
8015
1.17
1.20
4.1
4.1
mmol/l
1.3
1.3
0.59
735
7279
(3044889) 12 lead EKG panel
638
6075
1.14
1.18
3.6
4.0
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
0
33
0.00
1.16
0.0
1.1
—
32.6
—
0
27
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
14
82
1.72
1.05
1.0
1.1
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
9
48
1.88
1.00
1.8
6.4
—
48.1
—
0
12
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
7
35
2.01
1.00
1.3
1.9
nmol/l
1.0
6.9
—
7
27
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
23
2.18
0.98
1.2
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
23
2.18
0.98
1.2
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
37
276
1.35
0.96
5.5
6.2
mmol/l
1.3
1.2
0.15
31
245
(3037522) Nuclear Ab [Titer] in Serum
130
1126
1.18
0.96
1.3
1.3
titre
780.8
495.9
0.67
25
246
(3014271) Vancomycin [Susceptibility]
9
51
1.77
0.94
3.7
2.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
33
243
1.37
0.93
1.5
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
94
793
1.20
0.93
2.7
2.5
u/l
32.4
41.4
0.60
82
676
(4024509)
13
78
1.68
0.91
1.8
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
128
1113
1.17
0.91
5.0
4.6
%
32.3
32.5
0.07
77
727
(3034426) Prothrombin time (PT)
6
29
2.08
0.89
1.5
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
83
696
1.21
0.88
2.7
2.8
ml/min/173m2
60.6
64.7
0.46
34
288
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
56
452
1.25
0.85
2.4
2.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
6
31
1.94
0.84
1.3
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
28
205
1.38
0.84
2.0
1.4
mu/l
299.5
284.3
0.14
28
187
(4306422)
17
113
1.51
0.82
1.4
1.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
37
285
1.31
0.81
4.3
3.7
mg/l
36.1
47.3
0.27
29
235
(3034860) Kappa light chains.free [Mass/volume] in Serum
37
285
1.31
0.81
4.2
3.7
mg/l
51.5
73.1
0.40
29
233
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
47
1.71
0.80
1.0
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
13
200
0.65
0.80
3.2
3.3
nmol/l
0.7
0.8
—
7
158
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
58
1.73
0.80
1.1
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
25
0.00
0.79
0.0
1.5
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
26
0.00
0.78
0.0
1.3
—
116.2
—
0
18
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
26
0.00
0.78
0.0
1.2
—
33.6
—
0
13
(3013512) EKG study
283
2622
1.11
0.78
4.4
3.9
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
18
123
1.47
0.78
1.3
1.2
u/ml
1.8
2.4
—
8
33
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
69
577
1.21
0.77
3.5
3.8
kpa
5.0
5.1
1.72
60
543
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
805
7856
1.12
0.76
6.0
6.0
mmol/mol
39.3
40.1
1.71
728
7236
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
28
0.00
0.76
0.0
1.1
—
330.8
—
0
16
(3021788) Differential panel - Synovial fluid
23
166
1.39
0.76
1.6
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
53
1.70
0.75
1.0
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
25
184
1.37
0.74
2.1
2.2
g/l
130.5
128.5
0.13
17
137
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
21
150
1.41
0.73
4.0
2.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
294
2741
1.10
0.72
2.5
2.4
u/l
62.9
57.7
0.42
271
2535
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
56
464
1.22
0.70
2.5
3.3
pmol/l
4.6
4.5
0.13
51
402
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
142
0.63
0.70
1.1
1.1
—
—
—
0
0
(4268621)
13
85
1.54
0.69
2.8
2.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
199
1824
1.11
0.67
2.7
2.6
e6/l
5.0
5.7
0.40
171
1614
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
845
8285
1.12
0.67
4.9
4.7
mmol/l
5.8
6.0
3.16
752
7514
(3043410) Blood group antigens tested for on Red Blood Cells
5
28
1.79
0.66
1.6
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
141
1269
1.13
0.65
1.1
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
67
570
1.19
0.65
3.6
3.8
ph
7.4
7.4
—
9
73
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
160
1452
1.12
0.65
1.6
1.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
46
378
1.23
0.64
1.5
1.8
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
29
1.73
0.64
1.2
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
164
0.67
0.62
1.5
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
138
0.65
0.61
1.1
1.0
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
20
0.00
0.60
0.0
1.3
—
0.6
—
0
14
(3003694) ABO and Rh group [Type] in Blood
237
2206
1.10
0.60
1.3
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
2.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
20
148
1.36
0.60
1.5
1.4
—
—
—
0
0
(4027681)
8
52
1.54
0.59
1.3
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
21
157
1.34
0.59
2.7
1.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
141
1279
1.12
0.59
2.1
2.3
g/l
2.3
2.3
0.06
125
1187
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
64
1.57
0.58
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
64
1.57
0.58
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
64
1.57
0.58
1.1
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
54
636
0.84
0.58
4.0
4.2
%
0.1
0.6
0.42
14
173
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
234
2180
1.10
0.58
2.2
2.1
mg/l
3.0
3.1
0.24
198
1847
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
171
1860
0.90
0.58
1.7
1.6
mg/l
1.3
1.2
0.05
123
1425
(3004616) Nuclear Ab [Presence] in Serum
15
106
1.42
0.58
1.9
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
207
2227
0.91
0.57
4.5
4.2
estimate
0.0
0.0
0.50
76
764
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
36
1.67
0.56
1.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
36
1.67
0.56
1.0
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
132
1196
1.12
0.56
2.2
2.4
%
23.9
22.3
0.40
110
1030
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
44
366
1.21
0.56
3.7
4.2
mmol/l
24.4
24.9
0.81
39
348
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
17
124
1.38
0.56
1.4
1.2
u/ml
1.6
5.6
—
9
53
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
65
1.54
0.55
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
65
1.54
0.55
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
65
1.54
0.55
1.1
1.1
—
—
—
0
0
(4146454)
15
107
1.41
0.55
3.5
2.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
107
959
1.13
0.55
2.1
2.3
ug/g
152.3
132.3
0.22
81
763
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
60
1.50
0.54
1.2
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
74
1.49
0.53
1.0
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
62
1.46
0.53
1.3
1.5
—
—
—
0
0
(4211845)
6
39
1.54
0.53
3.8
3.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
22
282
0.78
0.52
1.0
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
139
1271
1.11
0.51
1.9
2.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
63
547
1.16
0.51
3.6
3.8
mmol/l
0.8
1.8
2.85
49
419
(3009261) Glucose [Presence] in Urine by Test strip
433
4160
1.07
0.50
3.8
3.9
estimate
0.0
0.0
0.50
77
758
(3021601) Nitrite [Presence] in Urine by Test strip
428
4111
1.07
0.50
5.2
5.2
estimate
0.0
0.0
0.00
76
789
(3019420) Tryptase [Mass/volume] in Serum or Plasma
7
45
1.56
0.49
1.3
1.2
ug/l
6.7
5.7
—
7
38
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
45
1.56
0.49
1.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
109
0.64
0.48
1.3
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
46
1.53
0.48
1.4
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
22
278
0.79
0.48
1.7
1.9
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
104
940
1.12
0.48
3.9
4.2
ug/l
15.0
24.8
0.35
84
784
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
76
1.45
0.48
1.1
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
48
1.46
0.47
1.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
25
200
1.26
0.46
1.3
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
25
200
1.26
0.46
1.3
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
16
120
1.34
0.46
1.3
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
13
176
0.74
0.46
1.3
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
49
1.43
0.46
1.4
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
49
1.43
0.46
1.4
1.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
81
0.62
0.46
1.0
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
14
187
0.75
0.46
3.1
3.6
mg/l
13.7
28.1
—
7
114
(3019832) Treponema pallidum Ab [Presence] in Serum
42
492
0.85
0.45
1.7
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
103
1.36
0.45
1.9
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
25
201
1.25
0.45
1.3
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
25
201
1.25
0.45
1.3
1.5
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
22
174
1.27
0.45
1.4
1.2
—
7.7
—
0
14
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
141
0.71
0.45
1.7
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
12
86
1.40
0.44
1.5
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
123
1129
1.10
0.44
1.3
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
23
184
1.26
0.43
1.3
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
127
0.71
0.43
1.7
1.5
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
8
57
1.41
0.42
1.9
2.0
ug/l
2.6
2.2
—
8
48
(3044941) Cell count panel - Synovial fluid
18
140
1.29
0.42
1.4
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
233
2204
1.07
0.42
3.7
3.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
353
3387
1.06
0.42
3.5
3.7
ng/l
40.1
50.9
0.22
247
2450
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
14
105
1.34
0.41
2.6
3.6
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
2.1
—
15.6
—
0
16
(3019309) Folate [Moles/volume] in Red Blood Cells
178
1668
1.08
0.41
1.7
1.7
nmol/l
1098.3
1194.4
0.74
132
1246
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
120
1105
1.10
0.41
7.0
7.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
33
390
0.84
0.41
1.0
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
23
186
1.24
0.40
4.5
3.8
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
34
1.47
0.40
2.6
3.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
31
260
1.20
0.39
1.7
1.6
iu/ml
0.0
0.1
—
5
45
(40760892) CBC W Ordered Manual Differential panel - Blood
170
1812
0.93
0.39
4.7
4.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
31
367
0.84
0.39
2.0
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
30
251
1.20
0.39
1.1
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
251
2637
0.94
0.39
2.7
3.0
ng/l
1396.4
1284.9
0.14
218
2254
(3028433) Virus identified in Specimen by Culture
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
71
1.41
0.39
1.7
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
177
1662
1.08
0.39
3.7
3.9
ng/l
122.7
318.1
1.98
145
1312
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
19
0.00
0.39
0.0
1.0
—
26.0
—
0
19
(3003327) Ova and parasites identified in Stool by Light microscopy
29
243
1.20
0.38
1.6
1.7
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
10
136
0.73
0.38
1.0
1.1
—
12.5
—
0
10
(3000475) Leukocytes [#/volume] in Synovial fluid
27
225
1.21
0.37
1.5
1.7
e6/l
11157.3
13721.3
0.16
22
164
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
14
107
1.31
0.37
1.1
1.0
u/ml
2.7
2.3
—
6
44
(3017181) Myelocytes/100 leukocytes in Blood
65
723
0.89
0.37
3.9
4.1
%
0.6
1.0
0.68
16
222
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
35
300
1.17
0.36
4.4
2.7
g/l
1.0
1.2
0.15
26
262
(3025130) Human papilloma virus identified in Specimen
11
81
1.36
0.36
1.5
1.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
12
90
1.34
0.36
1.3
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
78
0.64
0.35
1.2
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
13
99
1.32
0.35
1.1
1.3
mmol/l
6.2
7.2
—
8
64
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
43
1.40
0.35
1.0
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
19
233
0.81
0.35
1.2
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
66
595
1.12
0.35
5.2
4.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
25
209
1.20
0.34
1.4
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
71
781
0.90
0.34
2.7
2.4
ug/l
6.2
7.0
0.30
60
691
(3022313) Gas panel - Capillary blood
48
425
1.14
0.34
3.6
3.9
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
148
1390
1.08
0.33
2.1
2.3
umol/l
12.8
12.8
0.00
132
1286
(3036481) Cortisol [Moles/volume] in Serum or Plasma
86
789
1.10
0.33
2.9
2.1
nmol/l
361.2
376.4
0.26
78
727
(3000330) Specific gravity of Urine by Test strip
49
435
1.13
0.33
3.7
3.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
423
4106
1.05
0.33
3.8
3.8
estimate
0.0
0.0
0.00
71
778
(3049717) Cytology report of Urine Cyto stain
42
369
1.14
0.33
2.3
2.6
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
46
1.31
0.33
3.3
2.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
75
820
0.91
0.32
3.8
3.4
mmol/l
1.9
2.0
0.10
65
664
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
132
0.76
0.32
1.6
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
132
0.76
0.32
3.1
2.4
—
—
—
0
0
(4034850)
32
276
1.16
0.32
6.2
9.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
13
101
1.29
0.31
1.6
1.9
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
29
249
1.17
0.31
1.1
1.2
—
658.6
—
0
7
(44790048)
7
100
0.70
0.30
1.4
1.7
—
—
—
0
0
(44806118)
7
100
0.70
0.30
1.4
1.7
—
—
—
0
0
(44790049)
7
100
0.70
0.30
1.4
1.7
—
—
—
0
0
(44790047)
7
100
0.70
0.30
1.4
1.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
27
314
0.86
0.30
1.1
1.2
u/ml
0.2
1.4
—
7
23
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
55
1.27
0.30
1.1
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
130
0.77
0.29
1.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
57
1.23
0.29
2.0
2.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
18
216
0.83
0.28
1.5
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
27
233
1.16
0.27
1.1
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
124
1168
1.07
0.27
1.2
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
15
122
1.23
0.27
2.2
2.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
95
887
1.08
0.26
1.6
1.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
21
178
1.18
0.26
2.4
2.5
%
15.8
16.0
0.05
12
94
(40768800) Prostate Pathology biopsy report
14
171
0.82
0.26
1.1
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
11
86
1.28
0.26
1.0
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
10
77
1.30
0.26
1.7
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
133
1404
0.94
0.26
1.3
1.3
u/ml
33.7
13.6
0.32
49
528
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
20
235
0.85
0.26
3.0
2.4
ug/min
83.6
87.4
0.03
13
140
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
30
263
1.14
0.26
2.7
2.4
u/ml
0.3
0.4
0.10
20
147
(1761482) Bacteria [#/volume] in Urine by Culture
27
235
1.15
0.25
5.0
4.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
33
292
1.13
0.25
1.5
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
365
3553
1.04
0.25
2.8
2.7
ug/l
126.9
138.0
0.24
333
3254
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
77
1.17
0.24
1.6
1.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
39
433
0.90
0.24
3.3
3.3
mmol/l
25.6
25.4
0.16
39
422
(40768795) Lymph node Pathology biopsy report
6
81
0.74
0.24
1.2
1.1
—
—
—
0
0
(3020891) Body temperature
40
360
1.12
0.24
4.8
4.6
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
6
84
0.71
0.24
1.3
1.4
mmol/l
4.5
6.5
—
6
79
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
22
254
0.86
0.23
1.3
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
25
218
1.15
0.23
1.8
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
1.2
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
1.2
1.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
24
209
1.15
0.23
5.7
4.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
39
1.28
0.23
1.2
1.7
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
26
228
1.14
0.23
3.2
3.1
mmol/l
22.9
25.1
2.27
19
204
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
67
721
0.92
0.23
2.9
2.9
ng/l
126.7
193.8
1.34
59
663
(3017732) Neutrophils [#/volume] in Blood
61
564
1.09
0.22
3.3
3.1
e9/l
4.3
4.1
0.19
40
424
(3022217) INR in Platelet poor plasma by Coagulation assay
119
1129
1.06
0.22
19.0
25.4
inr
1.5
1.3
0.60
12
147
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
10
79
1.27
0.22
1.1
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
1.0
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
22
191
1.16
0.22
1.2
1.3
miu/ml
119.6
237.0
—
7
90
(3014051) Protein [Presence] in Urine by Test strip
22
191
1.16
0.22
1.6
2.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
24
210
1.15
0.22
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
16
135
1.19
0.21
1.9
2.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
11
0.00
0.21
0.0
2.8
—
0.6
—
0
11
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
5.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
61
656
0.93
0.21
3.5
4.0
%
0.5
0.5
0.05
14
164
(3042010) Triglyceride [Moles/volume] in Pleural fluid
0
13
0.00
0.21
0.0
1.1
—
0.9
—
0
8
(3027945) Reticulocytes/100 erythrocytes in Blood
104
986
1.06
0.20
2.3
2.6
%
1.8
1.8
0.21
92
878
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
48
1.25
0.20
1.7
1.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
15
176
0.85
0.20
6.7
3.7
%
56.3
57.5
0.09
15
176
(3021440) Promyelocytes/100 leukocytes in Blood
64
685
0.93
0.20
3.8
4.2
%
0.1
0.1
0.50
16
203
(3023368) Bacteria identified in Blood by Culture
247
2398
1.04
0.19
4.1
4.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
59
549
1.08
0.19
1.3
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
51
1.18
0.19
1.8
3.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
26
291
0.89
0.19
1.4
1.7
mg/l
1.2
2.9
2.35
19
213
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
18
207
0.87
0.19
1.5
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
10
81
1.24
0.18
3.0
2.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
51
549
0.93
0.18
4.0
3.0
g/l
132.9
127.9
1.03
51
538
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
228
2348
0.96
0.18
1.6
1.6
mmol/l
1.3
1.4
0.46
195
1960
(3005719) IgG [Mass/volume] in Serum or Plasma
70
659
1.07
0.18
3.7
2.9
g/l
11.0
10.8
0.10
63
602
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
91
1.21
0.17
1.0
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
40
368
1.09
0.17
1.9
2.0
ug/l
2.3
2.1
0.04
34
327
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
15
129
1.17
0.17
1.7
1.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
68
0.73
0.17
1.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
19
167
1.14
0.17
1.3
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
10
120
0.83
0.16
1.2
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
68
1.18
0.16
1.4
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
52
556
0.93
0.16
2.9
3.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
178
1837
0.96
0.16
3.9
4.2
kg/l
1.0
1.0
0.19
22
260
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
69
1.16
0.16
1.4
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
31
283
1.10
0.16
3.1
2.4
g/l
37.8
37.9
0.04
24
242
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
72
1.11
0.16
1.4
1.1
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
130
0.84
0.16
2.4
3.2
—
1949.9
—
0
15
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
17
193
0.88
0.16
1.2
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
76
0.79
0.15
1.0
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
102
977
1.05
0.15
2.6
2.8
umol/l
7.2
8.1
0.44
94
849
(3003740) Influenza virus B Ag [Presence] in Specimen
10
119
0.84
0.15
1.2
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
285
2912
0.97
0.15
3.0
2.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
20
178
1.13
0.15
1.9
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
280
2740
1.03
0.15
2.9
3.1
mmol/l
7.6
7.4
0.25
235
2288
(3023420) DNA double strand Ab [Units/volume] in Serum
9
82
1.10
0.15
1.7
1.3
—
35.7
—
0
6
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
67
635
1.06
0.15
2.1
1.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
83
1.09
0.14
1.8
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
87
0.80
0.14
1.1
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
87
0.80
0.14
1.1
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
87
0.80
0.14
1.1
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
90
0.78
0.14
1.1
2.0
—
—
—
0
0
(3000492) Spirometry study
75
787
0.95
0.14
1.7
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
18
160
1.13
0.14
2.8
2.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
16
141
1.14
0.14
1.7
2.2
u/l
3866.7
2332.7
—
8
58
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
98
0.81
0.13
4.3
3.9
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
99
0.81
0.13
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
99
0.81
0.13
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
99
0.81
0.13
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
99
0.81
0.13
1.3
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
100
0.80
0.13
1.6
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
165
1604
1.03
0.13
1.8
1.4
g/l
2.3
2.5
0.81
96
945
(3011397) Hemoglobin [Presence] in Urine by Test strip
199
1942
1.03
0.13
3.5
3.9
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
15
169
0.89
0.12
6.1
3.4
e9/l
4.7
4.3
0.09
15
169
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
130
1261
1.04
0.12
1.4
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
37
395
0.93
0.12
1.2
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
18
199
0.90
0.11
1.4
1.7
iu/l
2.7
5.5
—
7
57
(3010421) pH of Blood
25
230
1.09
0.11
5.1
4.2
ph
7.4
7.4
0.50
20
186
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
52
547
0.95
0.11
1.6
1.9
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
71
740
0.96
0.11
3.5
2.9
g/l
65.5
66.7
0.56
58
670
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
64
612
1.05
0.11
1.4
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
80
831
0.96
0.11
1.7
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
10
115
0.87
0.10
1.2
1.1
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
38
403
0.94
0.10
4.7
3.7
%
46.2
49.1
0.29
38
398
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
319
1.07
0.10
3.0
2.4
g/l
9.7
10.8
0.75
27
272
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
50
525
0.95
0.10
1.2
1.2
iu/ml
142.2
150.2
0.04
19
209
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
94
971
0.96
0.10
1.6
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
58
555
1.05
0.10
1.3
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
28
261
1.07
0.10
1.3
1.5
ug/g
298.1
288.3
0.10
17
154
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
44
1.14
0.10
1.6
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
55
526
1.05
0.10
1.3
1.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
55
526
1.05
0.10
3.7
1.7
g/l
2.1
1.5
0.51
47
483
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
45
1.11
0.10
4.8
6.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
45
1.11
0.10
1.0
1.3
nmol/l
123.6
153.4
—
5
45
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
114
0.88
0.09
1.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
116
1.12
0.09
1.4
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
76
734
1.04
0.09
3.4
3.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
14
155
0.90
0.09
1.4
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
11
124
0.89
0.09
1.5
2.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
18
165
1.09
0.08
1.7
1.7
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
6
57
1.05
0.08
2.0
1.9
—
42.6
—
0
9
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
20
216
0.92
0.08
1.6
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
42
440
0.95
0.08
1.2
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
62
0.81
0.08
2.0
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
63
0.79
0.08
1.6
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
68
703
0.96
0.08
5.0
4.1
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
40
419
0.95
0.08
3.3
2.5
%
0.7
0.6
0.75
40
404
(36660697) Celiac disease serology panel - Serum
63
651
0.97
0.07
1.2
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
82
0.85
0.07
1.3
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
82
0.85
0.07
1.3
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
84
0.83
0.07
1.3
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
19
204
0.93
0.07
1.4
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
85
1.06
0.07
3.0
2.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
118
1.10
0.07
1.2
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
8
90
0.89
0.06
1.8
2.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
92
0.87
0.06
1.6
1.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
95
0.84
0.06
1.5
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
279
2759
1.02
0.06
3.8
3.9
mg/mmol
16.5
7.9
0.36
162
1727
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
22
234
0.94
0.06
1.8
1.8
—
—
—
0
0
(1002224) Polysomnography panel
35
335
1.05
0.06
1.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
44
424
1.04
0.06
1.7
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
85
831
1.02
0.05
2.2
2.2
g/l
0.2
0.2
0.60
79
784
(3004588) Protein electrophoresis panel - Serum or Plasma
61
627
0.97
0.05
3.4
2.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
141
0.92
0.05
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
259
2616
0.99
0.05
3.1
3.2
mg/l
35.1
242.0
2.48
150
1657
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
318
3153
1.01
0.05
4.1
4.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
22
208
1.06
0.05
1.6
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
100
1.10
0.05
1.1
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
20
189
1.06
0.04
5.9
4.5
mmol/l
2.7
2.7
0.02
15
127
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
20
190
1.05
0.04
1.2
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
20
190
1.05
0.04
4.8
2.6
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
24
230
1.04
0.03
5.5
3.6
mg/l
1.6
1.6
0.06
19
208
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
14
149
0.94
0.03
5.9
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
16
151
1.06
0.03
1.3
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
227
2254
1.01
0.03
2.4
2.7
umol/l
352.7
6336.8
7.60
195
1932
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
102
1007
1.01
0.03
1.6
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
20
209
0.96
0.03
1.6
1.7
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
12
128
0.94
0.02
3.3
2.3
u/ml
7.6
35.8
0.44
12
122
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
28
289
0.97
0.02
1.9
1.9
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
15
158
0.95
0.02
1.3
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
91
921
0.99
0.02
2.2
1.7
%
1.4
1.5
0.47
81
794
(3045142) Bone marrow Pathology biopsy report
11
103
1.07
0.02
1.4
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
189
1901
0.99
0.01
1.6
1.7
pmol/l
441.2
25240046.9
1.67
149
1565
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
342
1.02
0.01
3.1
2.4
g/l
7.5
7.4
0.08
25
262
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
342
1.02
0.01
3.1
2.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
342
1.02
0.01
3.1
2.4
g/l
3.5
3.8
0.73
24
251
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
143
1.05
0.01
1.5
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
15
157
0.95
0.01
1.3
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
114
1149
0.99
0.01
1.9
1.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
323
1.02
0.01
3.1
2.4
g/l
3.2
3.2
0.05
25
255
(3018405) Lactate [Moles/volume] in Arterial blood
34
333
1.02
0.01
4.4
3.9
mmol/l
1.4
1.4
0.01
34
325
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
102
1012
1.01
0.01
1.6
1.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
114
1.05
0.00
2.1
1.8
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
11
116
0.95
0.00
3.7
2.0
pg
33.6
32.7
0.33
11
116
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
136
0.96
0.00
1.2
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
14
146
0.96
0.00
1.5
1.2
u/ml
198.4
280.2
—
9
82
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
181
1817
1.00
0.00
1.3
1.3
u/ml
1.0
1.8
0.98
40
481
(3024891) Influenza virus A+B Ag [Presence] in Specimen
24
234
1.03
0.00
1.1
1.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
40
394
1.02
0.00
1.6
1.8
g/l
1.7
1.5
0.67
34
347
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
90
906
0.99
0.00
3.4
3.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
25
246
1.02
0.00
1.1
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
11
108
1.02
0.00
1.3
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
12
122
0.98
0.00
1.3
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
12
122
0.98
0.00
1.3
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
14
138
1.01
0.00
1.7
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
74
736
1.01
0.00
3.2
2.6
e9/l
70.6
71.0
0.03
56
568
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
23
228
1.01
0.00
1.3
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
25
248
1.01
0.00
1.1
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
32
318
1.01
0.00
2.6
3.3
g/l
0.4
0.3
0.27
13
129
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
146
1464
1.00
0.00
1.4
1.3
iu/ml
57.3
34.3
0.73
43
485
(21494755) Public health laboratory ask at order entry panel
65
648
1.00
0.00
1.4
1.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
11
113
0.97
0.00
1.5
1.5
g/l
31.7
32.8
0.13
11
104
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
121
0.99
0.00
1.3
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
25
251
1.00
0.00
1.1
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
61
607
1.01
0.00
1.7
2.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
70
697
1.00
0.00
4.2
3.5
ng/l
91.1
84.5
0.20
60
612
(3026389) Candida sp identified in Specimen by Organism specific culture
10
105
0.95
0.00
1.0
1.3
—
—
—
0
0
(4281824)
9
95
0.95
0.00
1.4
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
51
0.98
0.00
2.0
1.6
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
51
0.98
0.00
2.0
1.6
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
9
89
1.01
0.00
1.3
1.2
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
8.0
—
0
5
(1617658) Protocol used for examination of sentinel lymph nodes
7
78
0.90
0.00
1.0
1.1
—
—
—
0
0
(3025315) Body weight
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.8
—
1.9
—
0
5
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
120
1.00
0.00
1.3
1.3
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
20.9
—
0
5
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
190
1.00
0.00
1.2
1.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.2
1.6
—
—
—
0
0
(4062490)
8
79
1.01
0.00
1.1
1.3
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
38.3
—
0
5
(3013762) Body weight Measured
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
91
0.99
0.00
1.3
1.8
—
—
—
0
0
(40758358) Immune stain study
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
63
630
1.00
0.00
1.3
1.4
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
120
1.00
0.00
1.3
1.3
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
12.4
—
0
9
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.2
1.6
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
12
120
1.00
0.00
1.3
1.3
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.2
1.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
65
0.92
0.00
9.8
1.6
%
11.3
10.9
—
6
65
(3044009) aPTT.lupus sensitive (LA screen)
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.2
1.6
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
55
0.91
0.00
1.2
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_CRANIAL_NERVE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_CRANIAL_NERVE | 1.104 [0.96, 1.27] | 0.176 |
| Birth year | 0.997 [0.99, 1.01] | 0.544 |
During the follow-up period (1.1.1998 — 31.12.2019), 312 out of 2291 females with CD2_BENIGN_CRANIAL_NERVE died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_CRANIAL_NERVE | 0.893 [0.77, 1.04] | 0.151 |
| Birth year | 0.987 [0.98, 1.0] | 0.008 |
During the follow-up period (1.1.1998 — 31.12.2019), 296 out of 1846 males with CD2_BENIGN_CRANIAL_NERVE died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_CRANIAL_NERVE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.106% | 0.216% |
| 5 | 0.569% | 1.193% |
| 10 | 1.639% | 2.809% |
| 15 | 3.339% | 5.148% |
| 20 | 5.606% | 8.77% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_CRANIAL_NERVE – Benign neoplasm: Cranial nerves
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data